C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
- Status
- COMPLETED
- Phase
- PHASE2
CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE4
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2